Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0ROG stock hub

LON/0ROG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0ROGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0ROG

In the news

Latest news · LON/0ROG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.8

P25 12.9P50 16.9P75 23.5

Trailing P/E22.9

P25 15.9P50 22.9P75 35.8

ROE12.1

P25 -54.2P50 2.1P75 13.7

ROIC7.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0ROG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CHF

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	6,577
Employees Change	456%
Employees Change Percent	5.72
Enterprise value	CHF 4.8B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	CH0360674466
Last refreshed	2026-05-10
Market cap	CHF 3.9B
Price	CHF 82.65
Price currency	CHF
Rev Per Employee	590,646.17x
Sector	Healthcare
Sic	5122
Symbol	lon/0ROG
Website	https://www.galenica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.37%
EV Earnings	28.07x
EV/EBIT	21.71x
EV/EBITDA	15.43x
EV/FCF	18.66x
EV/Sales	1.22x
FCF yield	6.57%
Forward P/E	20.78x
P/B ratio	2.79x
P/E ratio	22.91x
P/S ratio	1x
PE Ratio10 Y	19.29x
PE Ratio3 Y	22.4x
PE Ratio5 Y	19.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.47%
EBITDA Margin	6.45%
FCF margin	6.57%
Gross margin	12.17%
Gross Profit	CHF 472.8M
Gross Profit Growth	4.6%
Gross Profit Growth Q	9.74%
Gross Profit Growth3 Y	2.79%
Gross Profit Growth5 Y	2.37%
Net Income	CHF 169.7M
Net Income Growth	-1.01%
Net Income Growth Q	-10.8%
Net Income Growth Years	0%
Net Income Growth3 Y	0.72%
Net Income Growth5 Y	-7.62%
Pretax Margin	5.36%
Profit Margin	4.37%
Profit Per Employee	CHF 25,801
Profitable Years	12
ROA	4.45
Roa5y	4.49
ROCE	9.59
ROE	12.11
Roe5y	12.76
ROIC	7.78
Roic5y	8.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.54%
Cagr3y	5.03%
Cagr5y	9.32%
Div CAGR3	6.55%
Div CAGR5	10.79%
EPS Growth	-1.11
EPS Growth Q	-11.06
EPS Growth Years	0
EPS Growth3 Y	0.69
EPS Growth5 Y	-7.61
FCF Growth	19.62%
FCF Growth Q	-12.63%
FCF Growth3 Y	7.68%
FCF Growth5 Y	11%
OCF Growth	13.25%
OCF Growth Q	-13.6%
OCF Growth10 Y	2.94%
OCF Growth3 Y	4.25%
OCF Growth5 Y	8.15%
Revenue Growth	5.48x
Revenue Growth Q	5.82x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	2.92x
Revenue Growth5 Y	2.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 1.3
Assets	CHF 3.1B
Cash	CHF 108.2M
Current Assets	CHF 1B
Current Liabilities	CHF 881.5M
Debt	CHF 975.2M
Debt EBITDA	CHF 3.24
Debt Equity	CHF 0.7
Debt FCF	CHF 3.82
Equity	CHF 1.4B
Interest Coverage	16.85
Liabilities	CHF 1.7B
Long Term Assets	CHF 2.1B
Long Term Liabilities	CHF 816.5M
Net Cash	CHF -867M
Net Cash By Market Cap	CHF -22.31
Net Debt EBITDA	CHF 3.46
Net Debt Equity	CHF 0.62
Net Debt FCF	CHF 3.4
Tangible Book Value	CHF 63.7M
Tangible Book Value Per Share	CHF 1.28
WACC	5.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.15
Inventory Turnover	9.73
Net Working Capital	CHF 266.4M
Quick ratio	0.69
Working Capital	CHF 128.3M
Working Capital Turnover	CHF 17.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	10.28%
Dividend Growth Years	1%
Dividend per share	CHF 2.36
Dividend Years	9
Dividend Yield	2.86%
Ex Div Date	2026-04-23
Last Dividend	CHF 2.36
Payout Frequency	Annual
Payout Ratio	63.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.54%
200-day SMA	90.64
3Y total return	15.87%
50-day SMA	90.3
50-day SMA vs 200-day SMA	50under200
5Y total return	56.13%
All Time High	103
All Time High Change	-20.19%
All Time High Date	2026-02-18
All Time Low	39
All Time Low Change	110.77%
All Time Low Date	2017-04-07
ATR	1.54
Beta	0.29
Ch YTD	-15.86
High	83.1
High52	103
High52 Date	2026-02-18
High52ch	-19.76%
Low	82
Low52	81.7
Low52 Date	2026-05-04
Low52ch	1.16%
Ma50ch	-8.97%
Price vs 200-day SMA	-9.31%
RSI	26
RSI Monthly	47.81
RSI Weekly	36.11
Sharpe ratio	-0.36x
Sortino ratio	-0.16
Total Return	2.86%
Tr YTD	-13.41
Tr1m	-7.65%
Tr1w	-0.6%
Tr3m	-15.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 212.5M
Operating Income Growth	7.64
Operating Income Growth Q	15.35
Operating Income Growth3 Y	3.91
Operating Income Growth5 Y	4.56
Operating margin	5.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,674,827%
Net Borrowing	134,429,587.6
Shares Insiders	0.26%
Shares Institutions	39%
Shares Qo Q	0.06%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 248.3M
Average Volume	30,621.85x
Bv Per Share	27.87
CAPEX	CHF -25.7M
Ch1m	-10.26
Ch1w	-0.6
Ch1y	-6.27
Ch3m	-17.67
Ch3y	6.09
Ch5y	31.21
Ch6m	-4.6
Change	-0.42%
Change From Open	-0.54
Close	83
Days Gap	0.12
Depreciation Amortization	38,415,877.6
Dollar Volume	2,145,594
Earnings Date	2026-08-06
EBIT	CHF 212.5M
EBITDA	CHF 250.6M
EPS	CHF 3.4
F Score	5
FCF	CHF 255.2M
FCF EV Yield	5.36x
Financing CF	17,985,857
Fiscal Year End	December
Founded	1,927
Goodwill	983,823,284.6
Graham Number	49.01238
Graham Upside	-40.7
Income Tax	CHF 36.1M
Investing CF	-312,152,764
Is Primary Listing	0
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Lynch Fair Value	CHF 18.04
Lynch Upside	-78.17
Ma150	92.17
Ma150ch	-10.81%
Ma20	86.57
Ma20ch	-5.05%
Net CF	-13,282,080
Next Earnings Date	2026-08-06
Open	83.1
P FCF Ratio	15.23
P OCF Ratio	13.84
Payment Date	2026-04-27
Position In Range	59.09
Ppne	483,291,526.4
Price Date	2026-05-08
Price EBITDA	CHF 15.51
Ptbv Ratio	60.97
Relative Volume	0.85x
Revenue	3,884,679,857x
SBC By Revenue	0.18x
Share Based Comp	6,935,729
Tax By Revenue	0.93x
Tax Rate	17.31%
Tr6m	-1.82%
Volume	25,960
Z Score	3.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0ROG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.9%

$2.36 annual per share

Payout ratio

+63.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.8%

1 consecutive years of growth

Total shareholder yield

+2.9%

Next ex-dividend date: 2026-04-23

Performance

LON/0ROG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0ROG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.0%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

LON/0ROG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.0

Below 30: short-term oversold

Price vs 200-day MA

-9.3%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

-0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0ROG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0ROG stock rating?

lon/0ROG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0ROG analysis?

The full report lives at /stocks/lon/0ROG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0ROG?

The latest report frames lon/0ROG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0ROG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.